Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -136.7% | +594.8% | 2 / 3 | +17.5% | -0.44 pp | -2.52 pp | +10.4% | 0.68 | 4.30 | 93,4 | +17,5% | −0,5 | −134,3% | 4.30 | 41.68 | −89,7% |
| Pts | 0 | 12 | 8 | 8 | 4 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.000 (close price on 2026-10-19)EPS (TTM): 1.162
Financial charts
1.Revenue & growth
VND bn93,4Q2/26
1.Revenue & growth
VND bn93,4Q2/26
2.Profit & growth
VND bn-0,60Q2/26
3.Profit mix (Penman)
VND bn32,5Q2/26
4.Margins & cost structure
%10.6%Q2/26
5.Returns & cash cycle
% · days3.5%Q2/26
6.Earnings quality & cash
VND bn60,1Q2/26
7.Asset structure
VND bn633Q2/26
8.Funding & debt health
VND bn · times633Q2/26
9.Revenue backlog
VND bn35,8Q2/26
10.Valuation
times · %4,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-24Q2/26
Adjusted EPS growth, latest quarter
-137%
Average adjusted EPS growth, 3 quarters
595%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26